New Bipartisan Legislation Could Expand Access to Innovative Preeclampsia Testing – Preeclampsia Foundation
Preeclampsia Foundation shared on LinkedIn։
“New bipartisan legislation could help expand access to innovative testing for patients at risk of developing preeclampsia. The Preeclampsia Risk Evaluation and Evidence-based Management through Personalized Testing Act, or PREEMPT Act, would provide state Medicaid programs with important guidance on using blood-based biomarker tests throughout pregnancy.
These tests can help healthcare providers identify patients at elevated risk earlier and make more informed decisions about monitoring, treatment, and care. With hypertensive disorders of pregnancy remaining a leading cause of maternal illness and death, improving access to timely and effective testing is an important step toward protecting pregnant patients and their babies.
We need your support to help advance this legislation and ensure more families can benefit from innovative tools that may improve preeclampsia detection and management.
Contact your U.S. Representative and urge them to cosponsor the PREEMPT Act to accelerate access to tools and technologies that improve the care of pregnant women and reduce maternal morbidity and mortality. Use our tool to contact your Representative.
Please act now and share this with your networks!”
Stay informed with the latest updates in fertility and reproductive medicine on Fertility News.
-
Nov 2, 2026, 17:08Elena Milner: The 2nd Class of the School of Embryology Is Already in Full Swing
-
Nov 2, 2026, 17:05November Is National Diabetes Month – PCOS Awareness Association
-
Nov 2, 2026, 17:04Thanos Papathanasiou: Are We Preparing Patients for the IVF Cycle, or for the IVF Journey?
-
Nov 2, 2026, 17:02Anna Morales: Why Is It So Hard to Build in Women’s Health?
-
Nov 2, 2026, 16:59Rickard Ericsson: Honored to Take on the Role of Interim CEO of the Vitrolife Group
-
Nov 2, 2026, 16:56Mohammed Nasur: 1 Small Simulation, A Bigger Purpose
-
Nov 2, 2026, 16:54Carlos Guerrero: Presenting Our Latest Research on AI and Embryo Assessment at ASRM 2026
-
Nov 2, 2026, 16:52Sarah Lewen: My 1st ASRM Is Officially Complete
-
Nov 2, 2026, 16:49Jemma Garratt: Taking on the Role of Kind IVF and Data Science Manager at London Women’s Clinic